Abcam

Abcam supplies validated biological research tools to life scientists, with a catalogue spanning antibodies, proteins, kits and reagents that covers an exceptionally broad range of research targets. The company is recognised as a leading provider in this specialist sector, serving researchers who require high-confidence reagents to underpin reproducible results.

Among its current product highlights is the SimpleStep Ignite ELISA platform, which the company reports delivers 50x greater sensitivity and up to 35x broader measuring range than conventional ELISA formats, making it suited to studies where detecting low-abundance analytes is critical. Abcam also offers a portfolio of flow-validated antibodies covering approximately 90% of key metabolic enzymes, designed for immunometabolism and flow cytometry applications that require rare-cell-population resolution.

The catalogue includes more than 6,200 recombinant antibodies alongside 4,200-plus trial-size options, giving research teams flexibility in procurement and panel design. For spatial biology applications, the company provides IHC-validated antibodies that are among the most cited in the field, reflecting adoption by expert laboratories. An AI-powered product recommendation tool, MollAI, assists scientists in identifying suitable reagents, with the aim of reducing search time and supporting confident decision-making.

Abcam's standing within the research community is reflected in its recognition at the 2026 CiteAb Awards, where it received acknowledgement in three categories: IHC Supplier of the Year in Neuroscience, Highly Commended in the Phospho Antibody category, and the Significant Individual Impact Award for one of its scientists.

Further information is available at abcam.com.